Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population level.

Dilernia DA, Monaco DC, Cesar C, Krolewiecki AJ, Friedman SR, Cahn P, Salomon H.

PLoS One. 2013;8(1):e53193. doi: 10.1371/journal.pone.0053193. Epub 2013 Jan 7.

2.

Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.

Sanders GD, Anaya HD, Asch S, Hoang T, Golden JF, Bayoumi AM, Owens DK.

J Gen Intern Med. 2010 Jun;25(6):556-63. doi: 10.1007/s11606-010-1265-5. Epub 2010 Mar 4.

3.

Estimation of HIV incidence in the United States.

Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS; HIV Incidence Surveillance Group.

JAMA. 2008 Aug 6;300(5):520-9. doi: 10.1001/jama.300.5.520.

4.

Cost-effectiveness of HIV screening in patients older than 55 years of age.

Sanders GD, Bayoumi AM, Holodniy M, Owens DK.

Ann Intern Med. 2008 Jun 17;148(12):889-903.

5.

A retest of two HIV disclosure theories: the women's story.

Serovich JM, Lim JY, Mason TL.

Health Soc Work. 2008 Feb;33(1):23-31.

6.

Monitoring the incidence of HIV infection in the United States.

Lee LM, McKenna MT.

Public Health Rep. 2007;122 Suppl 1:72-9.

7.
8.

Prevalence of HIV infection among young adults in the United States: results from the Add Health study.

Morris M, Handcock MS, Miller WC, Ford CA, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR.

Am J Public Health. 2006 Jun;96(6):1091-7. Epub 2006 May 2.

9.

Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus.

Davenport MP, Ribeiro RM, Chao DL, Perelson AS.

J Virol. 2004 Oct;78(20):11340-51.

10.

If the condom fits, wear it: a qualitative study of young African-American men.

Crosby RA, Graham CA, Yarber WL, Sanders SA.

Sex Transm Infect. 2004 Aug;80(4):306-9.

12.

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS.

CMAJ. 2003 Sep 30;169(7):656-61.

13.

The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Hammett TM, Harmon MP, Rhodes W.

Am J Public Health. 2002 Nov;92(11):1789-94.

14.

Adherence discourse among African-American women taking HAART.

Sankar A, Luborsky M, Schuman P, Roberts G.

AIDS Care. 2002 Apr;14(2):203-18.

15.

HIV-associated histories, perceptions, and practices among low-income African American women: does rural residence matter?

Crosby RA, Yarber WL, DiClemente RJ, Wingood GM, Meyerson B.

Am J Public Health. 2002 Apr;92(4):655-9.

16.

Effectiveness of highly active antiretroviral therapy among HIV-1 infected women.

Gange SJ, Barrón Y, Greenblatt RM, Anastos K, Minkoff H, Young M, Kovacs A, Cohen M, Meyer WA 3rd, Muñoz A; Women's Interagency HIV Study Collaborative Study Group.

J Epidemiol Community Health. 2002 Feb;56(2):153-9.

17.
18.

HIV in the United States at the turn of the century: an epidemic in transition.

Karon JM, Fleming PL, Steketee RW, De Cock KM.

Am J Public Health. 2001 Jul;91(7):1060-8.

19.

Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997.

Weinhardt LS, Carey MP, Johnson BT, Bickham NL.

Am J Public Health. 1999 Sep;89(9):1397-405.

20.

Relative rates of AIDS among racial/ethnic groups by exposure categories.

Haverkos HW, Turner JF Jr, Moolchan ET, Cadet JL.

J Natl Med Assoc. 1999 Jan;91(1):17-24. Erratum in: J Natl Med Assoc 1999 Apr;91(4):192.

Items per page

Supplemental Content

Write to the Help Desk